CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$999,994. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-09-15 | Haqq Christopher EVP, R&D & Chief Scientific Of | Sale | −6,000 | $15.30 | $92K | 349,305 |
| 2017-09-07 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,200 | $14.98 | $33K | 437,378 |
| 2017-09-06 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,200 | $15.05 | $33K | 439,578 |
| 2017-08-23 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,200 | $13.51 | $30K | 441,778 |
| 2017-08-22 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,200 | $13.56 | $30K | 443,978 |
| 2017-08-16 | Gallagher Carol Giltner Director | Sale | −1,184 | $14.30 | $17K | 108,556 |
| 2017-08-16 | Soffer Gad EVP & Chief Strategy Officer | Sale | −2,464 | $14.53 | $36K | 259,090 |
| 2017-08-16 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −2,100 | $14.39 | $30K | 120,957 |
| 2017-08-16 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −3,021 | $14.33 | $43K | 159,130 |
| 2017-08-15 | Fust Matthew K Director | Option exercise | +1,603 | 28,901 | ||
| 2017-08-15 | Fust Matthew K Director | Option exercise · Restricted Stock Units | −1,603 | 3,739 | ||
| 2017-08-15 | Gallagher Carol Giltner Director | Option exercise | +1,548 | 108,922 | ||
| 2017-08-15 | Gallagher Carol Giltner Director | Option exercise | +818 | 109,740 | ||
| 2017-08-15 | Gallagher Carol Giltner Director | Option exercise · Restricted Stock Units | −1,548 | 3,097 | ||
| 2017-08-15 | Gallagher Carol Giltner Director | Option exercise · Restricted Stock Units | −818 | 2,179 | ||
| 2017-08-15 | Soffer Gad EVP & Chief Strategy Officer | Sale | −7,000 | $15.00 | $105K | 257,409 |
| 2017-08-15 | Soffer Gad EVP & Chief Strategy Officer | Option exercise | +4,145 | 261,554 | ||
| 2017-08-15 | Soffer Gad EVP & Chief Strategy Officer | Option exercise · Restricted Stock Units | −4,145 | 6,910 | ||
| 2017-08-15 | MCGRATH JOHN EVP & Chief Financial Officer | Option exercise | +7,697 | 125,157 | ||
| 2017-08-15 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −2,100 | $14.23 | $30K | 123,057 |
Page 41 of 44 · 867 trades